John Jenkins - Director at Corbus Pharmaceuticals Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
CRBP on Nasdaq
All Insider Reports
All Insider Reports

John Jenkins - trading volume in the past year for Corbus Pharmaceuticals Holdings, Inc.

Holdings reported by John Jenkins for Corbus Pharmaceuticals Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.0001 per share 2,816 $84,480 $30.00 30 May 2024 Direct
Common Stock, par value $0.0001 per share 4,833 $36,102 $7.47 30 May 2025 Direct
Stock options (right to buy) 16,000 30 May 2025 Direct Common Stock

Transactions reported by John Jenkins for Corbus Pharmaceuticals Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.